-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HJWxCwfUkHzs0DAgpMV5n+1yIYn0Jhlu/L6zkKL16DD8XQ4QduEaKFb8ZHt6hyat 1L6WMoZXD8Jqckw5O4SPRA== 0000014272-08-000108.txt : 20080306 0000014272-08-000108.hdr.sgml : 20080306 20080306172748 ACCESSION NUMBER: 0000014272-08-000108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080304 FILED AS OF DATE: 20080306 DATE AS OF CHANGE: 20080306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCBRIDE ANTHONY A CENTRAL INDEX KEY: 0001428699 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 08672023 BUSINESS ADDRESS: BUSINESS PHONE: 609-252-5580 MAIL ADDRESS: STREET 1: BRISTOL-MYERS SQUIBB COMPANY STREET 2: ROUTE 206 & PROVINCELINE ROAD CITY: LAWRENCEVILLE STATE: NJ ZIP: 08543 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 4 1 mcb840.xml X0202 4 2008-03-04 0 0000014272 BRISTOL MYERS SQUIBB CO (BMY) 0001428699 MCBRIDE ANTHONY A BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVINCELINE ROAD LAWRENCEVILLE NJ 08543 0 1 0 0 SVP Human Resources Executive Option (right to buy) 22.14 2008-03-04 4 A 0 83675 0 A 2018-03-03 Common Stock, $0.10 par value 83675.00 83675.00 D Restricted Stock Units 2008-03-04 4 A 0 6385 0 A Common Stock, $0.10 par value 6385.00 6385.00 D Option is not exercisable until the closing share price of common stock achieves a price of at least 15% above the option grant price and remains at that price for seven consecutive trading days. Shares vest 25% per year, on a cumulative basis, commencing one year after the grant date. Each restricted stock unit converts into one share of common stock upon vesting. One-third of the restricted stock units will vest on each of the third, fourth and fifth anniversaries of the grant date and be converted into shares of common stock. By: /s/ Sonia Vora, Attorney-in-Fact 2008-03-06 EX-24 2 mcbride.txt POWER OF ATTORNEY POWER OF ATTORNEY I, Anthony A. McBride, Vice President Human Resources, of Bristol-Myers Squibb Company, a corporation duly organized and existing under the laws of the State of Delaware, in the United States of America, and having its principal place of business at 345 Park Avenue, New York, New York, do hereby constitute and appoint each of Sonia Vora and Katherine Kelly individually,as my lawful attorney-in-fact and in my name, place and stead to execute and deliver any and all documents relating to insider reporting requirements under Section 16 of the Securities Exchange Act of 1934, including, without limitation, the execution and filing of all Forms 3, 4 and 5, and to take such other action, as such attorney considers necessary or appropriate, to effectuate such transactions until such time as I am no longer an officer of Bristol-Myers Squibb Company. IN WITNESS WHEREOF, I have executed this Power of Attorney on this 29th day of February 2008. /s/ Anthony A. McBride Anthony A. McBride -----END PRIVACY-ENHANCED MESSAGE-----